111 related articles for article (PubMed ID: 15953676)
1. Fractalkine gene therapy for neuroblastoma is more effective in combination with targeted IL-2.
Zeng Y; Jiang J; Huebener N; Wenkel J; Gaedicke G; Xiang R; Lode HN
Cancer Lett; 2005 Oct; 228(1-2):187-93. PubMed ID: 15953676
[TBL] [Abstract][Full Text] [Related]
2. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
[TBL] [Abstract][Full Text] [Related]
4. Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.
Kowalczyk A; Wierzbicki A; Gil M; Bambach B; Kaneko Y; Rokita H; Repasky E; Fenstermaker R; Brecher M; Ciesielski M; Kozbor D
Cancer Immunol Immunother; 2007 Sep; 56(9):1443-58. PubMed ID: 17597331
[TBL] [Abstract][Full Text] [Related]
5. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells.
Xin H; Kikuchi T; Andarini S; Ohkouchi S; Suzuki T; Nukiwa T; Huqun ; Hagiwara K; Honjo T; Saijo Y
Eur J Immunol; 2005 May; 35(5):1371-80. PubMed ID: 15789339
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha and IL-4 regulate expression of fractalkine (CX3CL1) as a membrane-anchored proadhesive protein and soluble chemotactic peptide on human fibroblasts.
Yoshikawa M; Nakajima T; Matsumoto K; Okada N; Tsukidate T; Iida M; Otori N; Haruna S; Moriyama H; Imai T; Saito H
FEBS Lett; 2004 Mar; 561(1-3):105-10. PubMed ID: 15013759
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector.
Gao JQ; Tsuda Y; Katayama K; Nakayama T; Hatanaka Y; Tani Y; Mizuguchi H; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
Cancer Res; 2003 Aug; 63(15):4420-5. PubMed ID: 12907614
[TBL] [Abstract][Full Text] [Related]
8. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow.
Lode HN; Xiang R; Varki NM; Dolman CS; Gillies SD; Reisfeld RA
J Natl Cancer Inst; 1997 Nov; 89(21):1586-94. PubMed ID: 9362156
[TBL] [Abstract][Full Text] [Related]
9. DNA minigene vaccination for adjuvant neuroblastoma therapy.
Lode HN; Huebener N; Zeng Y; Fest S; Weixler S; Gaedicke G
Ann N Y Acad Sci; 2004 Dec; 1028():113-21. PubMed ID: 15650237
[TBL] [Abstract][Full Text] [Related]
10. [Experimental gene therapy mediated by fractalkine (FK) for murine liver cancer].
Tang L; Hu P; Hu HD; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):675-7. PubMed ID: 16174457
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of alpha-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression.
Sung MJ; Kim W; Ahn SY; Cho CH; Koh GY; Moon SO; Kim DH; Lee S; Kang KP; Jang KY; Park SK
Circ Res; 2005 Oct; 97(9):880-90. PubMed ID: 16166554
[TBL] [Abstract][Full Text] [Related]
12. Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.
Kikuchi T; Andarini S; Xin H; Gomi K; Tokue Y; Saijo Y; Honjo T; Watanabe A; Nukiwa T
Infect Immun; 2005 Sep; 73(9):5350-7. PubMed ID: 16113250
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma.
Tang L; Hu HD; Hu P; Lan YH; Peng ML; Chen M; Ren H
Gene Ther; 2007 Aug; 14(16):1226-34. PubMed ID: 17597794
[TBL] [Abstract][Full Text] [Related]
14. Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells.
Zhang X; Wei H; Chen Q; Tian Z
Oncol Rep; 2007 Jun; 17(6):1371-5. PubMed ID: 17487393
[TBL] [Abstract][Full Text] [Related]
15. Quantitative gene expression analysis of fractalkine using laser microdissection in biopsies from kidney allografts with acute rejection.
Pietrzyk MC; Banas B; Wolf K; Rümmele P; Woenckhaus M; Hoffmann U; Krämer BK; Fischereder M
Transplant Proc; 2004 Nov; 36(9):2659-61. PubMed ID: 15621116
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
17. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
18. Expression and targeting of CX3CL1 (fractalkine) in renal tubular epithelial cells.
Durkan AM; Alexander RT; Liu GY; Rui M; Femia G; Robinson LA
J Am Soc Nephrol; 2007 Jan; 18(1):74-83. PubMed ID: 17151328
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of surface fractalkine by RNA interference in B16 melanoma reduced tumor growth in mice.
Ren T; Chen Q; Tian Z; Wei H
Biochem Biophys Res Commun; 2007 Dec; 364(4):978-84. PubMed ID: 17971299
[TBL] [Abstract][Full Text] [Related]
20. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
